David A. Ingram
- Genetics top 0.2%
- Mesenchymal stem cell research 8
- Neurology top 0.5%
- Neurofibromatosis and Schwannoma Cases 23
- Cancer Research top 1%
- Cancer, Hypoxia, and Metabolism 8
- Molecular Biology top 1%
- Angiogenesis and VEGF in Cancer 38
- Congenital heart defects research 12
- Cell Biology top 1%
- Zebrafish Biomedical Research Applications 9
-
- Neonatal Respiratory Health Research 11
-
- Congenital Diaphragmatic Hernia Studies 8
- Co-authors
- Mervin C. YöderLaura E. MeadDaniel N. PraterJamie CaseKaren K. HirschiFang LiKaren E. PollokHiromi Tanaka
- Cited by
- GeneticsNeurologyCancer Research
- Partner nations
- United StatesUnited KingdomIndia
In The Last Decade
David A. Ingram
119 papers receiving 10.1k citations
Hit Papers
Peers
Comparison fields: 5 of 143
- Genetics 1.9k
- Neurology 1.3k
- Cancer Research 1.2k
- Molecular Biology 5.4k
- Cell Biology 953
Countries citing papers authored by David A. Ingram
This map shows the geographic impact of David A. Ingram's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David A. Ingram with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David A. Ingram more than expected).
Fields of papers citing papers by David A. Ingram
This network shows the impact of papers produced by David A. Ingram. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David A. Ingram. The network helps show where David A. Ingram may publish in the future.
Co-authorship network
The 25 scholars most cited alongside David A. Ingram, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 5 | |
| 2 | 2017 | 124 | |
| 3 | 2016 | 22 | |
| 4 | Early pulmonary vascular disease in preterm infants at risk for bronchopulmonary dysplasia | 2015 | 5 |
| 5 | Early Pulmonary Vascular Disease in Preterm Infants at Risk for Bronchopulmonary Dysplasiabreakdown → | 2014 | 316 |
| 6 | Endothelial progenitor cells: identity defined? | 2009 | 6 |
| 7 | 2009 | 91 | |
| 8 | 2009 | 69 | |
| 9 | 2008 | 88 | |
| 10 | 2008 | 86 | |
| 11 | 2008 | 249 | |
| 12 | 2007 | 28 | |
| 13 | 2006 | 99 | |
| 14 | 2006 | 123 | |
| 15 | 2006 | 6 | |
| 16 | 2003 | 27 | |
| 17 | 2003 | 170 | |
| 18 | 1992 | 12 | |
| 19 | 1992 | 25 | |
| 20 | 1990 | 87 |
About David A. Ingram
David A. Ingram is a scholar working on Neurology, Genetics and Immunology and Allergy, having authored 119 papers that have together received 10.2k indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (38 papers), Neurofibromatosis and Schwannoma Cases (23 papers), Congenital heart defects research (12 papers), Neonatal Respiratory Health Research (11 papers), Zebrafish Biomedical Research Applications (9 papers), Congenital Diaphragmatic Hernia Studies (8 papers), Mesenchymal stem cell research (8 papers) and Cancer, Hypoxia, and Metabolism (8 papers). The work is most often cited by research in Genetics (1.9k citations), Neurology (1.3k citations) and Cancer Research (1.2k citations). David A. Ingram has collaborated with scholars based in United States, United Kingdom and India. Frequent co-authors include Mervin C. Yöder, Laura E. Mead, Daniel N. Prater, Jamie Case, Karen K. Hirschi, Fang Li, Karen E. Pollok, Hiromi Tanaka, David Gilley and Michael J. Ferkowicz. Their work appears in journals such as Blood, Journal of Clinical Investigation, Muscle & Nerve, Experimental Hematology and Human Molecular Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.